Skip to content
Home/Companies/Biotech/PetMedix
PE

PetMedix

Biotech·UK·Exited 2023·Held 4yr

PetMedix is a biotech company, headquartered in UK.

Entry
2019
Hold
4yr
Exit
2023
Est. EV
–

Who owns PetMedix?

PetMedix was owned by Parkwalk Advisors through Parkwalk Opportunities EIS Fund (2009 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-11

Parkwalk Advisors
Investor
Parkwalk Advisors
Parkwalk Opportunities EIS Fund · 2009 · VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from Parkwalk Opportunities EIS Fund

Other portfolio companies in the same fund.

Flusso
Exited 2022
Deep TechUK· 2020
to
Cytora
Exited 2025
SoftwareUK· 2015
to
Jukedeck
Exited 2019
AI/MLUK· 2014
to
VocalIQ
Exited 2015
AI/MLUK· 2014
to
Horizon Discovery
Exited 2017
BiotechUK· 2013
YASA
Exited 2021
MobilityUK· 2012
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings